<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Immunometabolic Gatekeeping: Reconciling Peto's & the T-cell Infiltration Prognostic Paradox - Health AI Hub</title>
    <meta name="description" content="This paper introduces an "immunometabolic gatekeeping" framework, positing that a host tissue's intrinsic metabolic intensity and waste-handling capacity are up">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Immunometabolic Gatekeeping: Reconciling Peto's & the T-cell Infiltration Prognostic Paradox</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.20883v1" target="_blank">2511.20883v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-25
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Naomi Iris van den Berg, Matou≈° Elphick, Kevin Mulder, Omar Bouricha, Omid Sadeghi-Alavijeh, Xiao Fu, Samra Turajlic
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.TO
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.20883v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.20883v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces an "immunometabolic gatekeeping" framework, positing that a host tissue's intrinsic metabolic intensity and waste-handling capacity are upstream determinants of anti-tumor immunity and cancer vulnerability, rather than solely tumor-intrinsic factors. It integrates evidence from human cancers and cross-species comparisons to reconcile several paradoxes, arguing that metabolically intense tissues create immune-exhausting niches even before malignant transformation.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This work provides a novel, integrative understanding of cancer vulnerability by shifting focus from tumor-intrinsic mutations to host-tissue metabolism, offering a crucial paradigm shift for cancer prevention, risk stratification, and the development of innovative therapeutic strategies that consider the host metabolic environment.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>While the abstract doesn't explicitly mention AI, the integration of 'human single-cell expression data' and the goal of 'identifying high-risk patients' present significant opportunities for AI applications. AI could be used to analyze complex multi-omic data to identify immunometabolic signatures, predict patient risk, stratify patients for targeted therapies, and design personalized metabolic-immune combination strategies. AI could also assist in drug discovery for metabolic modulators or immunotherapeutic agents based on the proposed 'immunometabolic gatekeeping' framework.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Classical cancer models often overlook the healthy tissue's metabolic environment as a critical factor influencing tumor development and immune efficacy.</li>
                    
                    <li>The authors propose that tissue-intrinsic metabolic intensity and waste-handling capacity act as an upstream 'immunometabolic gatekeeper' for anti-tumor immunity.</li>
                    
                    <li>Human cancers arising in high-metabolism tissues (e.g., kidney, brain, eye) frequently show high T cell infiltration but are associated with poor prognosis, suggesting pre-existing metabolic conditions undermine immune function.</li>
                    
                    <li>Cross-species comparisons support this framework: large mammals (Peto's paradox) with lower mass-specific metabolic rates exhibit reduced cancer incidence, while long-lived small mammals (bats, naked mole-rats) resist tumorigenesis via suppressed glycolysis or altered hypoxia responses.</li>
                    
                    <li>The 'immunometabolic gatekeeping' framework asserts that tissues with high metabolic rates and inefficient waste clearance foster immune-exhausting niches *prior* to malignant transformation.</li>
                    
                    <li>This unifying framework reconciles several long-standing paradoxes in cancer biology, including Peto's paradox, the T-cell infiltration prognostic paradox, tissue tropisms, and sex-based inequalities.</li>
                    
                    <li>The research suggests new principles for identifying high-risk patients and developing metabolic-immune combination strategies for cancer prevention and treatment.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employs an integrative synthesis approach, analyzing human single-cell expression data alongside extensive cross-species comparisons to develop and substantiate the 'immunometabolic gatekeeping' framework.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The main finding is the establishment of the 'immunometabolic gatekeeping' framework, which demonstrates that a tissue's intrinsic metabolic rate and waste clearance capacity create pre-malignant conditions that dictate the effectiveness of anti-tumor immunity. This framework successfully reconciles multiple paradoxes in cancer biology, offering a unified explanation for varying cancer vulnerabilities.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This framework has significant potential clinical impact by enabling the identification of high-risk patients based on their tissue metabolic profiles. It also opens avenues for developing novel metabolic-immune combination strategies for cancer prevention and treatment, potentially overcoming immune resistance and exhaustion by modulating the host metabolic environment.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract primarily presents a new conceptual framework and supporting evidence. It does not explicitly note specific limitations or caveats of the proposed model within its scope.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Suggested future research directions include applying the principles of immunometabolic gatekeeping to identify high-risk patients and to develop targeted metabolic-immune combination strategies for both cancer prevention and treatment.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Immunology</span>
                    
                    <span class="tag">Cancer Prevention</span>
                    
                    <span class="tag">Metabolic Diseases</span>
                    
                    <span class="tag">Precision Medicine</span>
                    
                    <span class="tag">Geriatric Oncology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Immunometabolism</span>
                    
                    <span class="tag tag-keyword">Peto's Paradox</span>
                    
                    <span class="tag tag-keyword">T-cell infiltration</span>
                    
                    <span class="tag tag-keyword">Cancer prognosis</span>
                    
                    <span class="tag tag-keyword">Host metabolism</span>
                    
                    <span class="tag tag-keyword">Metabolic waste</span>
                    
                    <span class="tag tag-keyword">Immune exhaustion</span>
                    
                    <span class="tag tag-keyword">Tissue tropism</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Classical models of cancer focus on tumour-intrinsic genetic aberrations and immune dynamics and often overlook how the metabolic environment of healthy tissues shapes tumour development and immune efficacy. Here, we propose that tissue-intrinsic metabolic intensity and waste-handling capacity act as an upstream gatekeeper of anti-tumour immunity, determining whether immune infiltration translates into effective immune function and safeguards the tissue from tumourigenesis. Across human cancers, tumours arising in high-metabolism tissues - like kidney, brain, and eye - tend to show high T cell infiltration but poor prognosis, suggesting pre-existing metabolic environments prior to malignant transformation may undermine immune function. This pattern is mirrored across species: large mammals with lower mass-specific metabolic rates (e.g., elephants, whales) accumulate fewer metabolic byproducts and show lower cancer incidence (Peto's paradox), while long-lived small mammals like bats and naked mole-rats resist tumourigenesis via suppressed glycolysis or altered hypoxia responses leading to lower metabolic rates and/or byproduct accumulation. Through integrative synthesis spanning human single-cell expression data and cross-species comparisons, we outline a framework of 'immunometabolic gatekeeping', where tissues with high metabolic rate and poor waste clearance foster immune-exhausting niches even before transformation. This unifying framework reconciles multiple paradoxes in cancer biology: Peto's paradox, T cell infiltration non-prognosticity, tissue tropisms, and sex-based inequalities, and suggests new principles for identifying high-risk patients and metabolic-immune combination strategies for prevention and treatment. By shifting focus from tumour-intrinsic mutations to host-tissue metabolism, this work offers a novel, integrative lens on cancer vulnerability and immune failure.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>31 pages (including Supplementary materials), 4 main figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>